Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C

Bryant A. Gilbert, Young Hee Lim, Jiabing Ding, John A. Badwey, Robert R. Rando

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Farnesylcysteine derivatives can initiate or inhibit superoxide (O2 -) release in neutrophils. The mechanism by which one of these derivatives, farnesyl thiotriazole (FTT), initiates O2 - release in neutrophils is the subject of this paper. Treatment of guinea pig neutrophils with FTT results in the rapid release of O2 - by a route shown to be independent of the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP) receptor. The signal transduction pathway utilized by the chemoattractant fMLP is generally accepted as the paradigm for receptor-mediated stimulation of O2 - production. Antagonists of fMLP had no effect on FTT-induced O2 - release, and pretreatment of neutrophils with fMLP had no effect on the ability of FTT to trigger further O2 - generation. In fact, FTT behaves like a ypical protein kinase C (PKC) activator. It promotes phosphorylation of the 47-kDa subunit of the NADH oxidase complex (p47-phox) in neutrophils, and this phosphorylation is specifically blocked by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7), an antagonist of PKC. FTT is also shown to activate PKC in vitro in a specific and saturable fashion. FTT is approximately equipotent with (S)-diolein, a physiologically relevant activator of this kinase. FTT represents a new, and quite novel, structure for a PKC activator. PKC activators include diglycerides and the structurally diverse tumor promoters.

Original languageEnglish
Pages (from-to)3916-3920
Number of pages5
JournalBiochemistry
Volume34
Issue number12
Publication statusPublished - 1995 Dec 1
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry

Cite this

Gilbert, B. A., Lim, Y. H., Ding, J., Badwey, J. A., & Rando, R. R. (1995). Farnesyl thiotriazole, a potent neutrophil agonist and structurally novel activator of protein kinase C. Biochemistry, 34(12), 3916-3920.